OM — Outset Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $205.22m
- $243.91m
- $113.69m
- 41
- 19
- 61
- 35
Annual cashflow statement for Outset Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -121 | -132 | -163 | -173 | -128 |
| Depreciation | |||||
| Non-Cash Items | 25.2 | 22.1 | 33.2 | 36.4 | 31.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.85 | -25.6 | -21.1 | -0.773 | -25.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -99 | -130 | -146 | -131 | -116 |
| Capital Expenditures | -9.11 | -3.11 | -8.32 | -3.44 | -0.912 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 13.1 | -139 | -58 | 86.5 | 105 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 3.95 | -143 | -66.3 | 83 | 104 |
| Financing Cash Flow Items | — | — | — | — | -0.938 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 386 | 160 | 72.9 | 43.7 | 67.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 291 | -113 | -139 | -4.7 | 55.5 |